SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-18-011277
Filing Date
2018-10-24
Accepted
2018-10-24 16:05:23
Documents
3
Period of Report
2018-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s113412_8k.htm 8-K 44004
2 EXHIBIT 10.1 s113412_ex10-1.htm EX-10.1 288519
3 EXHIBIT 10.2 s113412_ex10-2.htm EX-10.2 92658
  Complete submission text file 0001615774-18-011277.txt   426581
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 181136451
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences